One Week, One Boost, One Goal: Feasibility, Safety and Local Control in Breast Ductal Carcinoma In Situ With Ultra-hypofractionated Radiotherapy and Simultaneous Integrated Boost
{{output}}
Aims: Data on feasibility and safety of ultra-hypofractionated radiotherapy (UHF-RT) for ductal carcinoma in situ (DCIS) remain limited, particularly regarding its use with a simultaneous integrated boost (SIB). ... ...
